Clinical Trials

Brain and Nervous SystemPhase III Trial of Radiotherapy Followed by Adjuvant Temozolomide in Combination With the IDH Inhibitor Vorasidenib vs Placebo in IDH-Mutated Newly-Diagnosed Grade 3 Astrocytomas
BreastPalazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerPrincipal Investigator: Jing Du
Breast, Ovary, Phase IPhase 1/2A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients with Advanced Solid Tumors
Phase IA Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Brain and Nervous SystemA Phase 2 Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Silevertinib, an Oral EGFR Inhibitor, in Combination With Temozolomide in Patients With Newly Diagnosed Glioblastoma With Unmethylated MGMT Promoter and EGFRvIII